Table 4.
Antibiotics | Type of Cancer | Mechanism of Action | Ref |
---|---|---|---|
Adriamycin | Malignant lymphoma, breast cancer, lung cancer | - Inhibition of the activity of topoisomerase I and II causing the breakdown of DNA with two strands - Upregulation of p53 - Alteration of the Bcl-2/Bax pathway (changing the Bcl-2/Bax ratio) |
[217] |
Bleomycin | Lymphomas, germ cell tumors, melanomas, gynecologic cancers | - DNA binding - Production of free radicals (hydroxyl radicals) |
[218,219] |
Ciprofloxacin | Bladder cancer, colorectal cancer, hepatocellular carcinoma, melanoma, breast cancer | - Inhibition of the activity of topoisomerase II - Impairment of cell cycle at the G2 / M checkpoint |
[220,221] |
Dactinomycin | Nephroblastoma, chorionic epithelial carcinoma, rhabdomyosarcoma and neuroblastoma |
- Specific interaction with deoxyguanine in DNA - Formation of complexes with DNA - Inhibition of the mRNA synthesis |
[222,223] |
Daunorubicin | Acute myelogenous leukemia, lymphocytic leukemia |
- Chimerism between basic DNA pairs - Tight DNA binding - Obstruction of the spatial structure of DNA |
[224] |
Epirubicin | Breast cancer, malignant lymphoma, soft tissue sarcoma, gastric cancer, malignant melanoma, colon cancer, lung cancer, ovarian cancer | - Direct incorporation between DNA nucleotide pairs - Interfering with the transcription process and inhibiting mRNA formation - Topoisomerase II inhibition |
[216] |
Gemifloxacin | Breast cancer | - Inhibition of bacterial DNA gyrase and topoisomerase IV - Suppression of activity of NF-kB - Inhibition of the migration and invasion induced by cancer necrosis factor (TNF-α). |
[225,226] |
Mitomycin | Bladder cancer | - Formation of double cross-links or intrachain with DNA - Inhibition of DNA replication and synthesis - Increase in oxygen radicals |
[227,228] |
Plicamycin | Testicular embryonal cancer, glioma, lymphoma | - DNA binding - Inhibition of RNA synthesis - Acting on cell proliferation at all stages |
[229] |